14 studies were found.

1.		Recruiting	Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer Conditions: recurrent breast cancer; stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
2.		No longer recruiting	Chemotherapy in Treating Women With Resected Breast Cancer Following Tamoxifen Therapy Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
3.		Recruiting	Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
4.		No longer recruiting	Combination Chemotherapy in Treating Patients With Breast Cancer That Has Spread to the Lymph Nodes Conditions: stage I breast cancer; stage II breast cancer
5.		No longer recruiting	High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Combination Chemotherapy in Treating Women With High-Risk Breast Cancer Condition: Breast Cancer
6.		No longer recruiting	Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer Conditions: menopausal symptoms; stage I breast cancer; stage II breast cancer; breast cancer in situ
7.		No longer recruiting	Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer Conditions: stage II breast cancer; stage IIIA breast cancer
8.		No longer recruiting	Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; breast cancer in situ; recurrent breast cancer; ductal breast carcinoma; ...
9.		Recruiting	Suppression of Ovarian Function and Either Tamoxifen or Exemestane With or Without Chemotherapy in Treating Premenopausal Women With Resected Breast Cancer Conditions: stage IIIA breast cancer; stage I breast cancer; stage II breast cancer
10.		Recruiting	Suppression of Ovarian Function Plus Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
11.		No longer recruiting	Surgery With or Without Lymph Node Removal in Treating Older Women With Stage I or Stage IIA Breast Cancer Conditions: stage I breast cancer; stage II breast cancer
12.		Recruiting	Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases Conditions: stage II breast cancer; stage I breast cancer
13.		Recruiting	Trastuzumab in Treating Women With Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer
14.		Recruiting	Triptorelin Compared With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer